Role of BCL2L10 methylation and TET2 mutations in higher risk myelodysplastic syndromes treated with 5-Azacytidine
Role of BCL2L10 methylation and TET2 mutations in higher risk myelodysplastic syndromes treated with 5-azacytidine / MT. Voso , E. Fabiani , A. Piciocchi , C. Matteucci , L.Brandimarte , C. Finelli , E. Pogliani , E. Angelucci, G. Fioritoni , P. Musto , M. Greco , M. Criscuolo , L. Fianchi , M. Vignetti , V. Santini , S. Hohaus , C. Mecucci , G.Leone. - In: LEUKEMIA. - ISSN 0887-6924. - STAMPA. - 25:(2011), pp. 1910-1913. [10.1038/leu.2011.170]
Role of BCL2L10 methylation and TET2 mutations in higher risk myelodysplastic syndromes treated with 5-azacytidine.
SANTINI, VALERIA;
2011
Abstract
Role of BCL2L10 methylation and TET2 mutations in higher risk myelodysplastic syndromes treated with 5-Azacytidine
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
leu2011170.pdf
accesso aperto
Descrizione: Articolo
Tipologia:
Pdf editoriale (Version of record)
Licenza:
Open Access
Dimensione
326.41 kB
Formato
Adobe PDF
|
326.41 kB | Adobe PDF |
I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
